4.6 Article

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Journal

EUROPACE
Volume 23, Issue 10, Pages 1612-1676

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/europace/euab065

Keywords

NOACs; DOACs; apixaban; dabigatran; edoxaban; rivaroxaban

Funding

  1. Bayer Pharma AG
  2. Bristol-Myers Squibb
  3. Pfizer Alliance
  4. DaiichiSankyo Europe GmbH

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available